BRIEF published on 04/25/2025 at 14:05, 11 months 14 days ago Bausch Health Unveils Advanced Skin Resurfacing Technology at ASLMS 2025 Bausch Health Aesthetic Medicine Fraxel FTX™ Skin Resurfacing ASLMS 2025
PRESS RELEASE published on 04/25/2025 at 14:00, 11 months 14 days ago Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) Bausch Health unveiled Fraxel FTX™, the next-gen skin resurfacing tech, at ASLMS 2025, Orlando. Dual-wavelength laser treats skin concerns with visible results & minimal downtime Bausch Health Laser Technology Skin Resurfacing ASLMS 2025 Fraxel FTX
BRIEF published on 04/22/2025 at 13:30, 11 months 17 days ago Bausch Health Files Supplement to Proxy Statement Amid Icahn's Equity Swaps Proxy Statement Bausch Health Shareholder Rights Equity Swaps Carl Icahn
PRESS RELEASE published on 04/22/2025 at 13:25, 11 months 17 days ago Bausch Health Announces Filing of Supplement to Proxy Statement Bausch Health updates Proxy Statement to disclose 24.6% common shares held by Carl Icahn. Company adopts shareholder rights plan agreement to prevent 'creeping' take-over bids Proxy Statement Bausch Health Update Shareholder Rights Plan Carl Icahn
BRIEF published on 04/17/2025 at 21:45, 11 months 22 days ago Bausch Health Prevails in U.S. District Court Case Bausch Health Norwich Pharmaceuticals XIFAXAN® FDA Ruling Teva Exclusivity
PRESS RELEASE published on 04/17/2025 at 21:40, 11 months 22 days ago U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich Bausch Health and Salix Pharmaceuticals win U.S. District Court case against FDA regarding XIFAXAN, preserving patient access. Company to discuss financial results on April 30 FDA Financial Results Salix Pharmaceuticals XIFAXAN Bausch Health
BRIEF published on 04/14/2025 at 22:35, 11 months 25 days ago Bausch Health Adopts Shareholder Rights Plan Bausch Health TSX Approval Shareholder Rights Plan Take-over Protection Ratification Requirement
PRESS RELEASE published on 04/14/2025 at 22:30, 11 months 25 days ago Bausch Health Announces Adoption of Shareholder Rights Plan Bausch Health implements shareholder rights plan to safeguard fairness in take-over bids. Terms outlined for shareholder ratification within 6 months Bausch Health SRP Shareholder Rights Plan Take-over Bids Shareholder Ratification
BRIEF published on 04/10/2025 at 22:20, 11 months 29 days ago Bausch Health Launches 2025 ASPIRE HIGHER Scholarship Program Bausch Health Higher Education Scholarship Program Dermatologic Conditions 2025 Initiative
PRESS RELEASE published on 04/10/2025 at 22:15, 11 months 29 days ago Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program Bausch Health launches 2025 ASPIRE HIGHER Scholarship Program offering $10,000 scholarships to students impacted by dermatologic conditions. Application open until June 11, 2025 Bausch Health Education Scholarships Dermatologic Conditions ASPIRE HIGHER Scholarship Program
Published on 04/10/2026 at 02:15, 4 hours 32 minutes ago Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Published on 04/10/2026 at 01:05, 5 hours 42 minutes ago Pathfinder Ventures Inc. Announces Tranche Closing of Financing and Extension of Private Placement
Published on 04/10/2026 at 00:00, 6 hours 47 minutes ago Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Published on 04/09/2026 at 23:15, 7 hours 32 minutes ago Digi Power X Enters into Amended and Restated Sales Agreement
Published on 04/09/2026 at 22:00, 8 hours 47 minutes ago Invitation - First Quarter 2026 Trading Update Conference Call
Published on 04/09/2026 at 21:01, 9 hours 46 minutes ago GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Published on 04/09/2026 at 20:03, 10 hours 44 minutes ago Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:15, 12 hours 32 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 18:35, 12 hours 12 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 14 hours 50 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 23 hours 47 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 12 hours ago Publication of the 2025 Universal Registration Document
